The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Substudy F of the Canadian Cancer Trials Group (CCTG) IND.234: PC_BETS (Prostate Cancer Biomarker Enrichment and Treatment Selection)—A biomarker-selected phase II study of durvalumab and tremelilumab (DT) in patients (pts) with previously treated metastatic castration-resistant prostate cancer (mCRPC) resistant to AR pathway inhibitors (ARPI).
 
Sebastien Hotte
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Scientific and Medical Affairs Inc; Bayer
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); SignalChem (Inst)
 
Daniel Khalaf
Consulting or Advisory Role - Novartis
 
D. Ernst
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis Canada Pharmaceuticals Inc; Pfizer; Sanofi
Research Funding - Pfizer
 
Cristiano Ferrario
Honoraria - AstraZeneca; Bayer; Janssen Oncology; Merck; Novartis; Pfizer; Roche Canada; Seagen
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Merck; Novartis; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Michael Ong
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; EMD Serono; Janssen; Merck; Novartis / AAA; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Janssen; Merck; Pfizer/EMD Serono; Sanofi
Research Funding - AstraZeneca (Inst); BMS (Inst)
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Michael Kolinsky
Honoraria - AstraZeneca; Bayer; Eisai; EMD Serono; Janssen; Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck
Research Funding - Janssen (Inst)
 
Muhammad Salim
No Relationships to Disclose
 
Lucia Nappi
Honoraria - Bayer; Ipsen; Janssen; Pfizer; Tersera
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Novartis; Pfizer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - IVERMECTIN ANALOGUE COMPOUND THERAPEUTICS FOR HEAT SHOCK PROTEIN-27 (HSP27) INHIBITION, METHODS AND USES ASSOCIATED THEREWITH provisional number: 62/756,707
Travel, Accommodations, Expenses - Pfizer
 
Som Mukherjee
Speakers' Bureau - EMD Serono
Travel, Accommodations, Expenses - Amgen
 
Eric Winquist
Consulting or Advisory Role - Bayer; Eisai; EMD Serono; Ipsen; Merck; Roche
Research Funding - Lilly (Inst); Merck (Inst); Novartis (Inst)
 
April Rose
Employment - Merck (I)
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; EMD Serono; Pfizer
Research Funding - AstraZeneca Canada; AstraZeneca Canada (Inst); Canada Foundation for Innovation; Canadian Cancer Society; Canadian Institutes of Health Research (CIHR); Conquer Cancer Foundation; Jewish General Hospital Foundation; Merck (Inst); Pfizer; Pfizer (Inst); Seagen (Inst); TransMedTech Institute
Travel, Accommodations, Expenses - Pfizer
 
Kim Chi
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; BMS GmbH & Co. KG; Janssen; Merck; Novartis; Pfizer; POINT Biopharma; Roche
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BMS GmbH & Co. KG; Janssen; Merck; POINT Biopharma; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); ESSA (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Kylea Potvin
No Relationships to Disclose
 
Lesley Seymour
Stock and Other Ownership Interests - AstraZeneca
Research Funding - AstraZeneca (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Repare Therapeutics (Inst)
 
Edmond Kwan
No Relationships to Disclose
 
Martin Smoragiewicz
Consulting or Advisory Role - Astellas Pharma; Bayer; Eisai; EMD Serono; Ipsen; Janssen; McKesson; Merck
Speakers' Bureau - Astellas Pharma; Bayer; EMD Serono; Janssen; Merck
Travel, Accommodations, Expenses - Bayer
 
Hamid Ghaedi
Stock and Other Ownership Interests - ABSCI CORPORATION; AMYLYX PHARMACEUTICALS, INC; RELAY THERAPEUTICS, INC.
Consulting or Advisory Role - Roche Canada
 
Wei Tu
No Relationships to Disclose
 
Mariam Jafri
No Relationships to Disclose
 
Alexander Wyatt
Honoraria - AstraZeneca; Bayer; Janssen; Merck; Pfizer
Research Funding - ESSA (Inst); Promontory Therapeutics (Inst); Tyra Biosciences (Inst)